☰

Lucia Mazzacurati, Ph.D. - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
biochemistry, genetics
Tree Info Grants Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Yochum ZA, Cades J, Mazzacurati L, Neumann NM, Khetarpal SK, Chatterjee S, Wang H, Attar MA, Huang EH, Chatley SN, Nugent K, Somasundaram A, Engh J, Ewald AJ, Cho YJ, et al. A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-driven Lung Cancer. Molecular Cancer Research : McR. PMID 28851812 DOI: 10.1158/1541-7786.Mcr-17-0298  0.422
2015 Mazzacurati L, Lambert QT, Pradhan A, Griner LN, Huszar D, Reuther GW. The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells. Oncotarget. PMID 26472029 DOI: 10.18632/Oncotarget.5653  0.308
2015 Gajula RP, Chettiar ST, Williams RD, Nugent K, Kato Y, Wang H, Malek R, Taparra K, Cades J, Annadanam A, Yoon AR, Fertig E, Firulli BA, Mazzacurati L, Burns TF, et al. Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells. Neoplasia (New York, N.Y.). 17: 16-31. PMID 25622896 DOI: 10.1016/J.Neo.2014.10.009  0.374
2015 Mazzacurati L, Marzulli M, Reinhart B, Miyagawa Y, Uchida H, Goins WF, Li A, Kaur B, Caligiuri M, Cripe T, Chiocca EA, Chiocca N, Amankulor N, Cohen JB, Glorioso JC, et al. Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 99-107. PMID 25200130 DOI: 10.1038/Mt.2014.177  0.34
2014 Li A, Marzulli M, Mazzacurati L, Uchida H, Cohen J, Glorioso J, Grandi P. Abstract 703: Highly selective HSV virotherapy for glioblastoma Cancer Research. 74: 703-703. DOI: 10.1158/1538-7445.Am2014-703  0.385
2014 Chatley SN, Cades J, Neumann N, Mazzacurati L, Yochum Z, Nugent K, Cho Y, Ewald A, Rudin C, Tran P, Burns TF. Abstract 4771: Identification of inhibitors of TWIST1 as a treatment for lung cancer Cancer Research. 74: 4771-4771. DOI: 10.1158/1538-7445.Am2014-4771  0.407
2014 Mazzacurati L, Chatley SN, Yochum Z, Rudin CM, Tran PT, Burns TF. Abstract 3405: E12 and E47 are essential for TWIST1 dependent suppression of oncogene-induced senescence in NSCLC Cancer Research. 74: 3405-3405. DOI: 10.1158/1538-7445.Am2014-3405  0.402
2014 Li A, Marzulli M, Mazzacurati L, Kaur B, Bolyard C, Cohen J, Goins W, Zhang M, Glorioso J, Grandi P. ET-34 * HIGHLY SELECTIVE HSV VIROTHERAPY FOR TREATMENT OF GLIOBLASTOMA Neuro-Oncology. 16: v87-v87. DOI: 10.1093/Neuonc/Nou255.34  0.374
2013 Uchida H, Marzulli M, Nakano K, Goins WF, Chan J, Hong CS, Mazzacurati L, Yoo JY, Haseley A, Nakashima H, Baek H, Kwon H, Kumagai I, Kuroki M, Kaur B, et al. Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 561-9. PMID 23070115 DOI: 10.1038/Mt.2012.211  0.366
2012 Reinhart B, Mazzacurati L, Forero A, Hong CS, Eguchi J, Okada H, Fellows W, Niranjan A, Cohen JB, Glorioso JC, Grandi P. Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus. Advances in Virology. 2012: 815465. PMID 22924042 DOI: 10.1155/2012/815465  0.36
2009 Jin S, Gao H, Mazzacurati L, Wang Y, Fan W, Chen Q, Yu W, Wang M, Zhu X, Zhang C, Zhan Q. BRCA1 interaction of centrosomal protein Nlp is required for successful mitotic progression. The Journal of Biological Chemistry. 284: 22970-7. PMID 19509300 DOI: 10.1074/Jbc.M109.009134  0.331
2008 Matta H, Punj V, Schamus S, Mazzacurati L, Chen AM, Song R, Yang T, Chaudhary PM. A nuclear role for Kaposi's sarcoma-associated herpesvirus-encoded K13 protein in gene regulation. Oncogene. 27: 5243-53. PMID 18469854 DOI: 10.1038/Onc.2008.150  0.36
2007 Zhao J, Punj V, Matta H, Mazzacurati L, Schamus S, Yang Y, Yang T, Hong Y, Chaudhary PM. K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis. Plos One. 2: e1067. PMID 17957251 DOI: 10.1371/Journal.Pone.0001067  0.404
2007 Matta H, Mazzacurati L, Schamus S, Yang T, Sun Q, Chaudhary PM. Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation. The Journal of Biological Chemistry. 282: 24858-65. PMID 17597077 DOI: 10.1074/Jbc.M700118200  0.33
2007 Matta H, Surabhi RM, Zhao J, Punj V, Sun Q, Schamus S, Mazzacurati L, Chaudhary PM. Induction of spindle cell morphology in human vascular endothelial cells by human herpesvirus 8-encoded viral FLICE inhibitory protein K13. Oncogene. 26: 1656-60. PMID 16936773 DOI: 10.1038/Sj.Onc.1209931  0.39
2004 Mazzacurati L, Pattacini L, Brusa G, Mancini M, Benvenuti M, Barbieri E, Martinelli G, Baccarani M, Greenberger JS, Santucci MA. Chk2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571. The Hematology Journal : the Official Journal of the European Haematology Association / Eha. 5: 168-77. PMID 15048068 DOI: 10.1038/Sj.Thj.6200365  0.441
2004 Mancini M, Brusa G, Benvenuti M, Mazzacurati L, Campanini F, Barbieri E, Cammelli S, Calonghi N, Martinelli G, Baccarani M, Santucci MA. The p210BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene. Leukemia. 18: 370-2. PMID 14671649 DOI: 10.1038/Sj.Leu.2403207  0.343
2004 Pattacini L, Mancini M, Mazzacurati L, Brusa G, Benvenuti M, Martinelli G, Baccarani M, Santucci MA. Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase. Leukemia Research. 28: 191-202. PMID 14654084 DOI: 10.1016/S0145-2126(03)00218-2  0.327
2003 Jin S, Mazzacurati L, Zhu X, Tong T, Song Y, Shujuan S, Petrik KL, Rajasekaran B, Wu M, Zhan Q. Gadd45a contributes to p53 stabilization in response to DNA damage. Oncogene. 22: 8536-40. PMID 14627995 DOI: 10.1038/Sj.Onc.1206907  0.358
2002 Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X, Mazzacurati L, Li X, Petrik KL, Rajasekaran B, Wu M, Zhan Q. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene. 21: 8696-704. PMID 12483522 DOI: 10.1038/Sj.Onc.1206034  0.37
2002 Fan F, Jin S, Amundson SA, Tong T, Fan W, Zhao H, Zhu X, Mazzacurati L, Li X, Petrik KL, Fornace AJ, Rajasekaran B, Zhan Q. ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene. 21: 7488-96. PMID 12386811 DOI: 10.1038/Sj.Onc.1205896  0.402
Show low-probability matches.